In order to tailor the site to your needs, please click the button that relates best to you.
So long as you have cookies enabled you will only need to do this once. However, you can change your selection at any time using the dropdown navigation option above the CESPHN logo, top left.
This post is not the latest immunisation update and therefore may contain information or advice that is out of date. Please see our most recent update here.
The Australian Technical Advisory group on Immunisation (ATAGI) has reviewed their advice on the AstraZeneca COVID-19 vaccine, and Pfizer is now the preferred vaccine for people under 60 years.
People aged 50 to 59 years who are booked for their first dose of COVID-19 vaccine should be offered the Comirnaty Pfizer vaccine, instead of the COVID-19 AstraZeneca vaccine.
People of any age who have received their first dose of COVID-19 AstraZeneca vaccine without serious adverse effects should be offered the second dose of AstraZeneca vaccine
A new document Script for General Practices has been prepared to assist for General Practice staff in responding to patients with questions about the AstraZeneca COVID-19 vaccine. An FAQ document can be provided to patients to inform them of the changes.
Clinical alert – thrombosis with thrombocytopaenia syndrome (TTS) update
All people offered the COVID-19 AstraZeneca vaccine should be advised of the risk of TTS, the symptoms to watch out for in the 4 to 30 days following vaccination, and when to seek medical advice.
Symptoms of TTS include new onset of:
Persistent headaches with or without changes in vision, other focal neurology or seizure-like activity
Persistent abdominal pain
Leg swelling or pain with or without associated colour change
Chest pain and/or shortness of breath (without a clear alternative cause).
Clinical reminder
People presenting with symptoms of TTS in the 4 to 30 days after vaccination should be urgently investigated as per the latest ACEM and THANZ guidance.
New MBS item: immunisation consultations for patients over 50 years
A new MBS item 10660 has been introduced to support GPs to provide in-depth clinical assessments of patients aged 50 years and over regarding patients’ individual health risks and benefits associated with receiving a COVID-19 vaccine.
The benefit of $38.75 may only be claimed where a General Practitioner attends to a patient in person for more than 10 minutes, and must be provided in conjunction with a relevant MBS COVID-19 vaccine suitability assessment item.
The recommended interval between two doses of COVID-19 Vaccine AstraZeneca is 12 weeks.
Shortening the interval from 12 weeks to no less than4 weeks between doses is acceptable and may be appropriate in certain circumstances, for example, imminent travel or anticipated risk of COVID-19 exposure.
It is important to remind patients about their upcoming second dose appointment. A second dose flyer for patients receiving their COVID-19 vaccine is available for distribution.
COVID-19 vaccines in pregnancy and breastfeeding
The Department has updated the COVID-19 vaccination decision-making guide for women who are pregnant, breastfeeding, or planning pregnancy with information on Comirnaty (Pfizer).
Real-world evidence has shown that Comirnaty is safe for pregnant women and breastfeeding women. Pregnant women should be routinely offered Comirnaty at any stage of pregnancy, and women who are trying to become pregnant do not need to delay vaccination or avoid becoming pregnant after vaccination.
COVID-19 vaccination may provide indirect protection to babies by transferring antibodies through the placenta (for pregnant women) or through breastmilk (for breastfeeding women).
Vaccines administered by another provider: uploading to AIR
The Australian Immunisation Register (AIR) has functionality for immunisation providers to report vaccines that were administered by another provider.
If a patient has evidence of COVID-19 vaccinations (or any vaccinations) administered elsewhere which have not been reported to the AIR, providers are encouraged to report this information to ensure their patients have a complete AIR record.
The Department has commenced its campaign promoting the importance of influenza vaccinations for children, which are free for children aged 6 months to under 5 years under the National Immunisation Program (NIP).
Specialised resources developed under the Sharing Knowledge About Immunisation (SKAI) project are also available to support parents with questions about influenza vaccination for their children. These include:
Welcome to our new website! As you may have noticed, our website looks different. Central and Eastern Sydney PHN have moved to a new site and although much has remained the same, we have introduced some new functions. These include: Updated navigation When you land on our new website, you…
COVID-19 weekly update – 25 JANUARY 2023 COVID-19 cases in the region The number of reported COVID cases in our region has decreased over the last week and there are declines in hospital presentations, and residential aged care facility outbreaks. Infection control and wearing masks (staff and patients) is still…
FIVE QUESTIONS is where we ask members of the community to talk about how they stay HEALTHY. One Door Mental Health CEO Kathi Boorman shared this: 1. What exercise did you do yesterday? Most mornings, I get up at around 5 am and exercise for 30 minutes on my exercise…
Australian Digital Health Agency (ADHA) digital health foundations webinars The meaningful use of digital health in Australia is underpinned by healthcare organisations connecting to the Healthcare Identifiers (HI) service. This four-part webinar series will provide managers of medical practices, community pharmacies and other healthcare organisations with an understanding of the…
Palliative Care Resource Pack for Primary Care CareSearch has just released the Primary Health Care Resource Pack containing: communication starters, forms for assessing deterioration, forms to assess carer needs, a checklist of PBS prescriber medicines that can be used in terminal care, a practical checklist to guide and support a…
Palliative Care Resources for GPs CareSearch has now released printable versions of the reference guides to help GPs navigate CareSearch resources. These guides will direct you to actionable, relevant, evidence-based CareSearch resources to assist you in providing palliative care, including to specific populations. You can either download or order for…
New care finder services to assist older people in central and eastern Sydney The Central and Eastern Sydney Primary Health Network (CESPHN) is establishing a care finder program on behalf of the Australian Government. This follows recommendations from the Royal Commission into Aged Care Quality and Safety, which called for…